Q&A with Mrunal Jaywant: How the Discovery of Nitrosamines in Medicines Shifted the Pharmaceutical Manufacturing Landscape
Quality Matters
MAY 21, 2024
However, countries around the globe are at various stages of development for their regulatory policies. It can be overwhelming to know where to start to address nitrosamine impurities in drug products. Before the COVID pandemic, industry issues like this were often dealt with in a silo.
52 
Let's personalize your content